Medyria
Developer of a next-generation physiology assessment device intended to advance the diagnosis and treatment of heart ischemia. The company offers a comprehensive system capable of assessing full cardi...
Valuation
$29.3M
Market implied
Share Price
N/A
Total Raised
$16.2M
Last Round
N/A
12 investors — free account required
Sign up free Investors
+12 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details